OBI Pharma (4174)

Currency in TWD
31.65
0.00(0.00%)
Delayed Data·
4174 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4174 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
31.5032.55
52 wk Range
30.0092.60
Key Statistics
Bid/Ask
118.50 / 119.00
Prev. Close
58.4
Open
32.1
Day's Range
31.5-32.55
52 wk Range
30-92.6
Volume
-
Average Volume (3m)
1.17M
1-Year Change
-62.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4174 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

OBI Pharma Company Profile

OBI Pharma, Inc., a clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company’s pipeline products include Adagloxad simolenin which is in phase 3 for the treatment of triple-negative breast cancer; OBI-833 that is in phase 2 for the treatment of non-small cell lung cancer; OBI-3424 which has completed phase 2 for the treatment of liver hepatocellular carcinoma and acute lymphocytic leukemia; OBI-992 which is in phase 1 for the treatment of solid tumors; OBI-902 and OBI-904 that are in preclinical stage for the treatment of solid tumors; BsADC which is in discovery stage for the treatment of solid tumors. It also engages in investing and trading; and manufacture and wholesale of western pharmaceuticals, as well as research and development of biotechnology. OBI Pharma, Inc. was founded in 2002 and is headquartered in Taipei, Taiwan.

Compare 4174 to Peers and Sector

Metrics to compare
4174
Peers
Sector
Relationship
P/E Ratio
−3.5x−22.7x−0.6x
PEG Ratio
1.460.020.00
Price/Book
3.2x3.7x2.6x
Price / LTM Sales
134.8x36.8x3.3x
Upside (Analyst Target)
-0.0%38.7%
Fair Value Upside
Unlock−20.5%5.1%Unlock

Earnings

Latest Release
Aug 11, 2025
EPS / Forecast
-2.48 / --
Revenue / Forecast
12.76M / --
EPS Revisions
Last 90 days

4174 Income Statement

FAQ

What Stock Exchange Does OBI Pharma Trade On?

OBI Pharma is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for OBI Pharma?

The stock symbol for OBI Pharma is "4174."

What Is the OBI Pharma Market Cap?

As of today, OBI Pharma market cap is 8.32B.

What Is OBI Pharma's Earnings Per Share (TTM)?

The OBI Pharma EPS (TTM) is -9.63.

When Is the Next OBI Pharma Earnings Date?

OBI Pharma will release its next earnings report on 30 Oct 2025.

From a Technical Analysis Perspective, Is 4174 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has OBI Pharma Stock Split?

OBI Pharma has split 2 times.

How Many Employees Does OBI Pharma Have?

OBI Pharma has 0 employees.

What is the current trading status of OBI Pharma (4174)?

As of 28 Aug 2025, OBI Pharma (4174) is trading at a price of 31.65, with a previous close of 58.40. The stock has fluctuated within a day range of 31.50 to 32.55, while its 52-week range spans from 30.00 to 92.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.